Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Call for open access to all clinical trial data

October 6, 2011 Research and Development Cochrane, clinical trials, clinical trials analysis

There should be free access to all clinical trials in order to end selective reporting, according to a leading not-for-profit …
News

Merck appoints new chief strategy officer

October 6, 2011 Manufacturing and Production, Research and Development, Sales and Marketing appointment, manufacturing and production, research and development, sales and marketing

Cuong Viet Do has joined Merck & Co as chief strategy officer, replacing Mervyn Turner who retired from the US …
Appointment
Merck Serono

Merck KGaA signs MS and cancer research deal

October 5, 2011 Research and Development Merck KGaA

Merck KGaA has signed development deals with Japanese firm Ono Pharmaceutical Co around two investigational treatments, one for multiple sclerosis …
News

Blocking pain – a long-term mission for pharma research

October 5, 2011 Research and Development chronic pain, neuropathic pain, pain therapeutics

Pain is a common, yet complex, clinical problem and one which remains an area of unmet need. There are however, …
Feature

Contract research news in brief

October 5, 2011 Research and Development research and development news

Clinipace raises $15m, PPD appoints a new chief executive and there are updates from Quintiles, PharmaNet and DaVita Clinical Research. …
News
sm

Steve Mott joins DrugLogic

October 5, 2011 Research and Development appointment, outcomes research, personalised medicine, pharmacovigilance, research and development

Former Datapharm Communications chief executive Steve Mott has been apppointed UK managing director by DrugLogic.The US firm develops analytical tools …
Appointment
adaptimmune_helen_tm1

Adaptimmune makes board appointments

October 4, 2011 Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

UK and US-based cell therapy company Adaptimmune has made two new appointments to its board. Dr Jonathan Knowles joins as …
Appointment

Trial disappointment for AZ lung cancer drug

October 3, 2011 Research and Development, Sales and Marketing AstraZeneca, selumetinib

AstraZeneca’s lung cancer drug selumetinib has failed to hit its primary endpoint in a Phase II trial. The trial compared …
News

Chiltern expands North American Operation with a new office in Illinois

September 30, 2011 Research and Development

 Mr. Barry Simms, Chiltern’s Country Manager, North America, commented, “Chiltern continues to look for opportunities to increase our strategic footprint …
News
Press release

Astellas abandons oral anticoagulant darexaban

September 30, 2011 Research and Development Astellas, Eliquis, Xarelto, darexaban

Astellas Pharma has abandoned the development of its oral direct factor Xa inhibitor darexaban. The Japanese firm blamed both the …
News

R&D jobs in emerging markets – leaders wanted

September 29, 2011 Business Services, Research and Development Jobs, careers, pharma jobs

The globalisation of pharmaceutical research and development is creating a wave of job opportunities in emerging markets such as India …
Feature

NICE blames pharma R&D model for spiralling cancer drug costs

September 29, 2011 Research and Development, Sales and Marketing Cancer, NICE, clincial trials

NICE has blamed the pharma industry’s ‘inefficient’ and increasingly costly R&D model for the rising price of cancer drugs. NICE …
News

Researchers call for European clinical trial reform

September 28, 2011 Research and Development Euorpe, clinical trials

Medical researchers are calling for regulatory red tape to be snipped away from the legal requirements around clinical trials in …
News

Lilly launches ‘open innovation’ drug discovery

September 28, 2011 Research and Development OIDD, TB, lilly

Lilly has launched a new open innovation platform designed to help build its pipeline and to identify new treatments for …
News

Roche’s Herceptin successor impresses at EMCC

September 27, 2011 Research and Development Herceptin, Roche, TDM-1

Roche’s next-generation breast cancer drug T-DM1 has impressed at the European cancer congress after besting Herceptin in a new study. …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025